Sudden increase of the ST segment elevation at time of reperfusion predicts extensive infarcts in patients with intravenous thrombolysis

Am Heart J. 1993 Oct;126(4):832-9. doi: 10.1016/0002-8703(93)90696-7.

Abstract

Within 4 hours from the onset of symptoms in 61 patients with myocardial infarction and intravenous thrombolysis, ST segment elevation and creatine phosphokinase (CK) were measured every 15 minutes. Because of a premature enzyme rise, 42 patients (69%) were reperfused early (group 1). Immediately following reperfusion, eight of them (13%, group 1a) showed a marked increase of the ST elevation, in six of whom it was associated with clearly intensified chest pain. These patients exhibited a much steeper enzyme release and developed a larger enzymatic infarct size than patients (group 1b) without an additional transient ST elevation at reperfusion (CK peak 5.1 +/- 1.6 vs 9.8 +/- 4.2 hours after the start of thrombolysis; CK release 48 +/- 22 vs 19 +/- 18 IU/ml x hours, both p < 0.005). At angiography 11 days later, left ventricular function was significantly worse in group 1a than in group 1b (regional dyssynergic area 51 +/- 24 vs 21 +/- 18, global ejection fraction 39 +/- 14 vs 58 +/- 11; both p < 0.0005). During intravenous thrombolysis in acute myocardial infarction, some patients show a marked transient increase of the ST segment elevation at reperfusion. Their enzyme rise is very rapid and suggests a special reperfusion pattern. Most of these patients suffered large infarcts.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Anistreplase / administration & dosage*
  • Cardiac Catheterization
  • Chi-Square Distribution
  • Clinical Enzyme Tests / statistics & numerical data
  • Coronary Angiography
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Electrocardiography / drug effects*
  • Electrocardiography / statistics & numerical data
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / epidemiology
  • Prognosis
  • Streptokinase / administration & dosage*
  • Thrombolytic Therapy / methods*
  • Time Factors
  • Urokinase-Type Plasminogen Activator / administration & dosage*

Substances

  • Anistreplase
  • Streptokinase
  • Urokinase-Type Plasminogen Activator